This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Incidence

Authoring team

  • soft tissue sarcomas account for approximately 1% of all malignant tumours
    • approximately 2,300 people were diagnosed annually with soft tissue sarcoma in England between 1990 and 2007
      • no significant differences in age-standardised incidence rates between males and females
      • more than 65% of cases occurred in people aged 50 and over. Between 1990 and 2007, the incidence rate increased significantly by 26%. However, it is uncertain if these increases are caused by true rises in incidence, improved awareness and diagnosis, or better reporting and coding

    • majority of soft tissue sarcomas occur in patients aged 50 and over - an age profile similar to many carcinomas
      • however, the age profile of patients diagnosed with soft tissue sarcoma depends on the morphology of the sarcoma. Leiomyosarcomas and liposarcomas are two examples of a soft tissue sarcoma which is most common in the elderly, rhabdomysarcomas are most common in children and adolescents, and synovial sarcomas have a higher occurrence in young adults

    • 5-year relative survival for soft tissue sarcomas diagnosed in England was only 47% for patients diagnosed in 1990 and 51% for patients diagnosed in 2002. This small improvement is not statistically significant

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.